CONTRARIUS GROUP HOLDINGS LTD
Q3 2025 Form 13-F

HAMILTON, BERMUDA
CIK 0002054801 · Institutional investment manager
Consolidated report · includes 3 managers since Q4 2024
$2.2B Reported Value Total
Reported value
$2.2B
Quarter over quarter
+26.2%
Holdings
52
Top-10 concentration
62.6%

Filing Structure

Reports holdings for

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Matt De Kock
Director

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2025 13F record

Q3 2025 13F filing summary

Q3 2025 Form 13F portfolio summary
Period of report September 30, 2025
Filed November 12, 2025
Form 13F-HR
Reported value $2.2B
Positions 52
Change in reported value +24.8%
New positions 8
Exited positions 13
Position turnover 32.3%
Top-10 concentration 62.6%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 10, 2026
25 $2.1B
Q2 2026 13F
Filed Aug 11, 2026
34 $2.2B
Q1 2026 13F
Filed May 11, 2026
39 $1.8B
Q4 2025 13F
Filed Feb 11, 2026
44 $2.1B
Q3 2025 13F
Filed Nov 12, 2025
52 $2.2B
Q2 2025 13F
Filed Aug 12, 2025
57 $1.8B
Q1 2025 13F
Filed May 12, 2025
49 $1.5B
Q4 2024 13F
Filed Feb 11, 2025
42 $1.6B

Top 20 holdings · Q3 2025

Largest Q3 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 TSLA TESLA INC $236.9M 10.72%
2 WBD WARNER BROS DISCOVERY INC $230.5M 10.44%
3 PSKY PARAMOUNT SKYDANCE CORP $186.7M 8.45%
4 FOX FOX CORP $135.9M 6.15%
5 BIDU BAIDU INC $117.5M 5.32%
6 NTLA INTELLIA THERAPEUTICS INC $101.7M 4.6%
7 SATS ECHOSTAR CORP $98.8M 4.47%
8 DELL DELL TECHNOLOGIES INC $92.7M 4.2%
9 TSM TAIWAN SEMICONDUCTOR MFG LTD $90.9M 4.11%
10 MU MICRON TECHNOLOGY INC $90.0M 4.07%
11 NVDA NVIDIA CORPORATION $82.6M 3.74%
12 COIN COINBASE GLOBAL INC $81.8M 3.7%
13 INTC INTEL CORP $74.1M 3.35%
14 BABA ALIBABA GROUP HLDG LTD $65.3M 2.95%
15 META META PLATFORMS INC $63.0M 2.85%
16 AMD ADVANCED MICRO DEVICES INC $59.8M 2.71%
17 BEAM BEAM THERAPEUTICS INC $37.2M 1.68%
18 JD JD.COM INC $35.9M 1.62%
19 GOOGL ALPHABET INC $30.0M 1.36%
20 CRSP CRISPR THERAPEUTICS AG $17.5M 0.79%

Values as reported on the Q3 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings